CRISPR Therapeutics AG (CRSP)
57.33
-2.67
(-4.45%)
USD |
NASDAQ |
Mar 05, 16:00
57.06
-0.27
(-0.47%)
After-Hours: 05:14
CRISPR Therapeutics Cash from Investing (Quarterly) : 37.20M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -288.10M |
| Beam Therapeutics, Inc. | 108.41M |
| Novartis AG | -2.111B |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -92.55M |
| Cash from Financing (Quarterly) | 116.41M |
| Free Cash Flow | -345.93M |
| Free Cash Flow Per Share (Quarterly) | -0.9769 |
| Free Cash Flow to Equity (Quarterly) | -88.79M |
| Free Cash Flow to Firm (Quarterly) | -93.07M |
| Free Cash Flow Yield | -6.71% |